Berkshire Hathaway Inc. New (BRK-B) › Analysis

Berkshire Hathaway Inc. New (BRK-B) analysis, October 10, 2025

Published October 10, 2025 · BRK-B chart, levels and live analysis

Key Updates

Berkshire Hathaway (BRK-B) fell 2.21% since the last report to $489.06, ending a short-term rally. The headline event was the announcement of the largest deal in years – the acquisition of OxyChem, the chemicals unit of Occidental Petroleum, for $9.7 billion in cash, showing Warren Buffett’s renewed investment activity.

Current Trend

The stock is in a short-term correction after the September rebound. At $489.06, BRK-B is up 7.89% year-to-date but down 5.19% over the past six months. A recent 1.94% drop over five days signals consolidation following the big Occidental deal.

Investment Thesis

The thesis rests on Berkshire’s ability to deploy excess cash through strategic acquisitions and a diversified asset base. The $9.7 billion OxyChem purchase confirms management’s willingness to make large investments when valuations look attractive.

Thesis Status

The thesis gains further support. Buying OxyChem shows active cash deployment for strategic growth, meeting shareholder expectations for efficient capital use. The deal strengthens Berkshire’s position in chemicals and adds diversification.

Key Drivers

The primary driver is the announcement of the $9.7 billion OxyChem acquisition, the biggest deal in years. The transaction will help Occidental cut debt and focus on its oil-and-gas business. Zacks analysts highlight BRK-B as a company with strong earnings growth and long-term potential.

Technical Picture

BRK-B trades at $489.06, about $11.04 below the prior high of $500.10. The stock is in a short-term pullback after the September rally. The $500 level acts as near-term resistance, while support may form around $480-$485. A YTD gain of 7.89% keeps the medium-to-long-term trend positive.

Bull Case

  • The biggest deal in years – the $9.7 billion OxyChem purchase – shows active capital deployment (Morningstar)
  • Favorable terms with Occidental, giving Berkshire a chemical asset at an attractive price (Barron's)
  • Analyst recognition as a leader with strong earnings growth and long-term upside (Zacks)
  • Portfolio diversification beyond the “Magnificent 7” tech names (Zacks)
  • Positive YTD performance (+7.89%) confirms the resilience of the business model

Bear Case

  • Spending $9.7 billion could temporarily tighten liquidity for other investments (WSJ)
  • A 5.19% decline over six months signals medium-term pressure on the stock
  • Short-term pullback of 2.21% since the last report
  • Negative five-day momentum (-1.94%) could persist in the near term
  • Buffett’s approaching retirement creates uncertainty about future leadership (Morningstar)
Get a message when the BRK-B picture changes — the agent team watches the levels and the news for you.Create a free account

More BRK-B analyses